Set & SettingLSDPsilocybin

Narratives of the mystical among users of psychedelics

Drawing on interviews with 50 psychedelic users, this study finds that contemporary psychedelic “mystical” experiences conform to archetypal narratives characterised by transcendence of time and space, intense euphoria and a felt oneness with a larger whole. These archetypal patterns are shaped by culturally and politically specific storylines, notably environmental motifs of unity with plants and animals and a perceived duty to protect nature.

Authors

  • Heith Copes

Published

Acta Sociologica
individual Study

Abstract

We are now witnessing a radical revival in clinical research on the use of psychedelics (e.g. LSD and psilocybin), where ‘mystical’ experiences are at the centre. Drawing on in-depth interviews with 50 psychedelic drug users, we document how they draw on archetypical mystical narratives, comprising three key dimensions: (1) the transcendence of time and space; (2) deep euphoria; and (3) the perception of being at one with ‘a larger whole’. We suggest that the evolving new cultures around the use of psychedelics contain a variety of narratives, with clear roots in traditional mystical thinking. At the same time, these narratives reflect current cultural and political influences, including the narratives of oneness with plants and animals and our perceived need to protect nature. We conclude that the way people experience mystical occasions due to psychedelic use have archetypical patterns, but culturally specific storylines.

Available with Blossom Pro

Research Summary of 'Narratives of the mystical among users of psychedelics'

Introduction

Mystical experiences have long been central to religious and philosophical accounts of human meaning, and recent clinical revival around psychedelics (for example LSD and psilocybin) has placed such experiences back at the centre of scientific interest. Classical dimensions of mysticism—ineffability, noetic quality, unity or loss of ego, and altered sense of time and space—are repeatedly reported in studies of psychedelic administration, yet most empirical work has been clinical and limited in examining how users outside therapeutic settings make sense of these events. There is also an ongoing debate about whether mystical experiences are universal in their core features or are culturally mediated by narrative resources available to the experiencer. Pedersen and colleagues set out to explore how people in Norway narratively construct and explain mystical experiences occasioned by psychedelics. Using a narrative identity framework, the study examines which cultural storylines participants draw on—particularly contemporary ecological and political themes—to render the ineffable intelligible and to account for reported personal changes following psychedelic use. The authors therefore aim to document both archetypal patterns of mystical experience and the culturally specific storylines that shape their interpretation.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

  • Study Type
    individual
  • Journal
  • Compounds
  • Topic
  • Author
  • APA Citation

    Pedersen, W., Copes, H., & Gashi, L. (2021). Narratives of the mystical among users of psychedelics. Acta Sociologica, 64(2), 230-246. https://doi.org/10.1177/0001699320980050

References (15)

Papers cited by this study that are also in Blossom

The paradoxical psychological effects of lysergic acid diethylamide (LSD)

Carhart-Harris, R. L., Kaelen, M., Bolstridge, M. et al. · Psychological Medicine (2016)

253 cited
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences

Gashi, L., Sandberg, S., Pedersen, W. · International Journal of Drug Policy (2021)

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

Hendricks, P. S., Thorne, C. B., Clark, B. et al. · Journal of Psychopharmacology (2015)

345 cited
MDMA enhances emotional empathy and prosocial behavior

´dric, C., Hysek, M., Schmid, Y. et al. · Social Cognitive and Affective Neuroscience (2013)

Potential Therapeutic Effects of Psilocybin

Johnson, M. W., Griffiths, R. R. · Neurotherapeutics (2017)

Powerful substances in tiny amounts An interview study of psychedelic microdosing

Johnstad, P. G. · Nordic Studies on Alcohol and Drugs (2018)

121 cited
Show all 15 references
Modern clinical research on LSD

Liechti, M. E. · Neuropsychopharmacology (2017)

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

Maclean, K. A., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2011)

Psychiatry & the psychedelic drugs. Past, present & future

Rucker, J., Iliff, J., Nutt, D. J. · Neuropharmacology (2017)

Narrative identity, rationality, and microdosing classic psychedelics

Webb, M., Copes, H., Hendricks, P. S. · International Journal of Drug Policy (2019)

Cited By (2)

Papers in Blossom that reference this study

Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors

Ponomarenko, P., Seragnoli, F., Calder, A. et al. · Journal of Psychopharmacology (2023)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.